To compare the efficacy and safety in patients treated with travoprost versus dorzolamide/timolol maleate combination in patients with open-angle glaucoma or ocular...
Date First Received: May 8, 2007
Last Updated: May 22, 2008
Verified by: Alcon Research, May 2008
Clinical Trial Phase: Phase 4 | Start Date: March 2007
Overall Status: Recruiting
Estimated Enrollment: 80
Brief Summary
Official Title: “Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension”
Condition Keyword(s):
Intervention(s):
To compare the efficacy and safety in patients treated with travoprost versus dorzolamide/timolol maleate combination in patients with open-angle glaucoma or ocular hypertension
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Study Primary Completion Date: May 2009
Intervention(s) in this Clinical Trial
- Drug: Travatan
Outcome Measures for this Clinical Trial
Primary Measures
- IOP
- Time Frame: Duration
- Time Frame: Duration
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Patient with open-angle glaucoma or ocular hypertension
Exclusion Criteria:
- By Age
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Alcon Research
Overall Clinical Trial Officials and Contacts
Anna Grau Study Director Alcon Research
Overall Contact: Anna Grau +34 934977000
Additional Information
Information obtained from ClinicalTrials.gov on October 10, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00471068
Study ID Number: EMD-05-03
ClinicalTrials.gov Identifier: NCT00471068
Health Authority: Infarmed:Portugal
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
